Annual Net Margin
-38.24 K%
-34.64 K%-962.54%
31 December 2023
Summary:
Spyre Therapeutics annual net profit margin is currently -38.24 thousand%, with the most recent change of -34.64 thousand% (-962.54%) on 31 December 2023. During the last 3 years, it has fallen by -37.89 thousand% (-10789.72%). SYRE annual net margin is now -20500.23% below its all-time high of -185.62%, reached on 01 December 2015.SYRE Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
N/A
30 September 2024
Summary:
Spyre Therapeutics quarterly net profit margin is not available.SYRE Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -962.5% | - |
| 3 y3 years | -10000.0% | - |
| 5 y5 years | - | - |
SYRE Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | ||
| 5 y | 5 years | <-9999.0% | at low | ||
| alltime | all time | <-9999.0% | at low |
Spyre Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -38.24 K%(+962.5%) | - |
| June 2023 | - | -31.55 K%(+239.1%) |
| Mar 2023 | - | -9304.04%(-17.0%) |
| Dec 2022 | -3598.75%(+924.9%) | - |
| Dec 2022 | - | -11.20 K%(+6.9%) |
| Sept 2022 | - | -10.48 K%(+193.4%) |
| June 2022 | - | -3571.68%(+99.1%) |
| Mar 2022 | - | -1794.13%(+219.8%) |
| Dec 2021 | -351.14%(-69.2%) | -561.09%(-61.3%) |
| Sept 2021 | - | -1451.54%(+2810.6%) |
| June 2021 | - | -49.87%(-87.4%) |
| Dec 2018 | -1140.64% | - |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | -395.88%(-26.4%) |
| Mar 2018 | - | -537.68%(+22.9%) |
| Dec 2017 | -523.27%(+11.6%) | -437.45%(-29.9%) |
| Sept 2017 | - | -624.43%(+39.3%) |
| June 2017 | - | -448.41%(-29.5%) |
| Mar 2017 | - | -636.15%(+44.7%) |
| Dec 2016 | -468.84%(+152.6%) | -439.70%(-19.0%) |
| Sept 2016 | - | -542.91%(+37.3%) |
| June 2016 | - | -395.48%(-25.3%) |
| Mar 2016 | - | -529.34%(+110.4%) |
| Dec 2015 | -185.62% | -251.55%(-20.9%) |
| Sept 2015 | - | -318.08%(+663.9%) |
| June 2015 | - | -41.64% |
FAQ
- What is Spyre Therapeutics annual net profit margin?
- What is the all time high annual net margin for Spyre Therapeutics?
- What is Spyre Therapeutics annual net margin year-on-year change?
- What is the all time high quarterly net margin for Spyre Therapeutics?
What is Spyre Therapeutics annual net profit margin?
The current annual net margin of SYRE is -38.24 K%
What is the all time high annual net margin for Spyre Therapeutics?
Spyre Therapeutics all-time high annual net profit margin is -185.62%
What is Spyre Therapeutics annual net margin year-on-year change?
Over the past year, SYRE annual net profit margin has changed by -34.64 K% (-962.54%)
What is the all time high quarterly net margin for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly net profit margin is -41.64%